Details for New Drug Application (NDA): 217071
✉ Email this page to a colleague
The generic ingredient in ERTUGLIFLOZIN is ertugliflozin. Two suppliers are listed for this compound. Additional details are available on the ertugliflozin profile page.
Summary for 217071
Tradename: | ERTUGLIFLOZIN |
Applicant: | Hetero Labs Ltd V |
Ingredient: | ertugliflozin |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Sep 17, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
Approval Date: | Sep 17, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription